Order Intake Growth Despite Challenges
Order intake grew despite a double-digit decline in China, driven by double-digit order intake growth in North America and strength in Diagnosis & Treatment.
Strong Innovation Impact
More than 50% of sales are fueled by AI-driven innovations from new and upgraded products launched in the last three years, showcasing the power of Philips' innovation strategy.
Resilient Adjusted EBITA Margin
Adjusted EBITA margin delivery was resilient at 8.6% despite lower sales, driven by productivity measures and innovation.
Improved Free Cash Flow Excluding Settlement
Excluding the €1 billion Respironics settlement payment, free cash flow increased by €270 million year-on-year, driven by higher earnings and lower working capital outflows.